Lv1
40 积分 2025-09-14 加入
肝癌影像疗效评价标准的历史、现状与展望
1天前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
1个月前
已完结
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
1个月前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
2个月前
已完结
Management of Hepatocellular Carcinoma: A Review
2个月前
已完结
肝细胞癌转化和新辅助治疗的进展与挑战
2个月前
已完结
Precision surgery for hepatocellular carcinoma
2个月前
已完结
Hepatic artery infusion chemotherapy (HAIC) combined with sintilimab and bevacizumab biosimilar (IBI305) for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial
4个月前
已关闭
Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1) A Multi-institutional Study by the Kyushu Study Group of Liver Surgery
4个月前
已完结
Conversion Surgery after lmmune CheckpointInhibitor-Based Combination Therapy forInitially Unresectable Hepatocellular Carcinoma:A Retrospective cohort Study
4个月前
已完结
皖公网安备34019202002308
